KISS1 and endometriosis: This integrated mechanistic view provides a strong rationale for exploring KiSS-1 analogues or agonists to therapeutically modulate lesion progression or invasive behavior in endometriosis and other pathologies sharing metastatic-like features (Matsui and Asami, 2014; Blake et al., 2017).